Suppr超能文献

利用蛋白缀合物改变细胞命运。

Manipulating Cell Fates with Protein Conjugates.

机构信息

Department of Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, United States.

Department of Medicinal Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, United States.

出版信息

Bioconjug Chem. 2022 Oct 19;33(10):1771-1784. doi: 10.1021/acs.bioconjchem.2c00226. Epub 2022 Aug 15.

Abstract

The homeostasis of cellular activities is essential for the normal functioning of living organisms. Hence, the ability to regulate the fates of cells is of great significance for both fundamental chemical biology studies and therapeutic development. Despite the notable success of small-molecule drugs that normally act on cellular protein functions, current clinical challenges have highlighted the use of macromolecules to tune cell function for improved therapeutic outcomes. As a class of hybrid biomacromolecules gaining rapidly increasing attention, protein conjugates have exhibited great potential as versatile tools to manipulate cell function for therapeutic applications, including cancer treatment, tissue engineering, and regenerative medicine. Therefore, recent progress in the design and assembly of protein conjugates used to regulate cell function is discussed in this review. The protein conjugates covered here are classified into three different categories based on their mechanisms of action and relevant applications: (1) regulation of intercellular interactions; (2) intervention in intracellular biological pathways; (3) termination of cell proliferation. Within each genre, a variety of protein conjugate scaffolds are discussed, which contain a diverse array of grafted molecules, such as lipids, oligonucleotides, synthetic polymers, and small molecules, with an emphasis on their conjugation methodologies and potential biomedical applications. While the current generation of protein conjugates is focused largely on delivery, the next generation is expected to address issues of site-specific conjugation, stability, controllability, target selectivity, and biocompatibility.

摘要

细胞活动的动态平衡对于生物的正常运作至关重要。因此,调控细胞命运的能力对于基础化学生物学研究和治疗开发都具有重要意义。尽管小分子药物通常作用于细胞蛋白功能,并取得了显著的成功,但当前的临床挑战凸显了使用大分子来调节细胞功能以提高治疗效果的必要性。作为一类日益受到广泛关注的杂化生物大分子,蛋白质偶联物已显示出作为多功能工具来调控细胞功能以用于治疗应用(包括癌症治疗、组织工程和再生医学)的巨大潜力。因此,本文讨论了用于调控细胞功能的蛋白质偶联物的设计和组装的最新进展。此处涵盖的蛋白质偶联物根据其作用机制和相关应用分为三类:(1)调节细胞间相互作用;(2)干预细胞内生物途径;(3)终止细胞增殖。在每种类型中,都讨论了多种蛋白质偶联物支架,其中包含各种接枝分子,如脂质、寡核苷酸、合成聚合物和小分子,并重点介绍了它们的偶联方法和潜在的生物医学应用。虽然当前一代的蛋白质偶联物主要集中在递送方面,但下一代预计将解决定点偶联、稳定性、可控性、靶向选择性和生物相容性等问题。

相似文献

1
Manipulating Cell Fates with Protein Conjugates.
Bioconjug Chem. 2022 Oct 19;33(10):1771-1784. doi: 10.1021/acs.bioconjchem.2c00226. Epub 2022 Aug 15.
2
Controlled Radical Polymerization as an Enabling Approach for the Next Generation of Protein-Polymer Conjugates.
Acc Chem Res. 2016 Sep 20;49(9):1777-85. doi: 10.1021/acs.accounts.6b00258. Epub 2016 Sep 2.
3
Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
Phys Biol. 2013 Aug;10(4):040301. doi: 10.1088/1478-3975/10/4/040301. Epub 2013 Aug 2.
4
Responsive polymer conjugates for drug delivery applications: recent advances in bioconjugation methodologies.
J Drug Target. 2019 Apr;27(4):355-366. doi: 10.1080/1061186X.2018.1499747. Epub 2018 Sep 7.
5
"Bio"-macromolecules: polymer-protein conjugates as emerging scaffolds for therapeutics.
Macromol Rapid Commun. 2014 Jan;35(1):27-43. doi: 10.1002/marc.201300792. Epub 2013 Dec 9.
6
Well-defined protein-polymer conjugates--synthesis and potential applications.
Appl Microbiol Biotechnol. 2006 Nov;73(2):243-54. doi: 10.1007/s00253-006-0574-4. Epub 2006 Oct 24.
7
Water-Soluble Conjugated Organic Molecules as Optical and Electrochemical Materials for Interdisciplinary Biological Applications.
Acc Chem Res. 2019 Nov 19;52(11):3211-3222. doi: 10.1021/acs.accounts.9b00427. Epub 2019 Oct 14.
8
Macromolecule-drug conjugates in targeted cancer chemotherapy.
Crit Rev Ther Drug Carrier Syst. 1984;1(1):1-38.
10
Advances in intracellular delivery through supramolecular self-assembly of oligonucleotides and peptides.
Theranostics. 2019 May 18;9(11):3191-3212. doi: 10.7150/thno.33921. eCollection 2019.

引用本文的文献

1
Light-Activated Reactivity of Nitrones with Amino Acids and Proteins.
Angew Chem Int Ed Engl. 2025 Jan 21;64(4):e202415976. doi: 10.1002/anie.202415976. Epub 2024 Nov 22.

本文引用的文献

1
Improving the efficiency of CRISPR-Cas12a-based genome editing with site-specific covalent Cas12a-crRNA conjugates.
Mol Cell. 2021 Nov 18;81(22):4747-4756.e7. doi: 10.1016/j.molcel.2021.09.021. Epub 2021 Oct 13.
2
Modular Assembly of Tumor-Penetrating and Oligomeric Nanozyme Based on Intrinsically Self-Assembling Protein Nanocages.
Adv Mater. 2021 Oct;33(39):e2103128. doi: 10.1002/adma.202103128. Epub 2021 Aug 5.
4
The current landscape of nucleic acid therapeutics.
Nat Nanotechnol. 2021 Jun;16(6):630-643. doi: 10.1038/s41565-021-00898-0. Epub 2021 May 31.
5
An update on actively targeted liposomes in advanced drug delivery to glioma.
Int J Pharm. 2021 Jun 1;602:120645. doi: 10.1016/j.ijpharm.2021.120645. Epub 2021 Apr 27.
6
CAR-T cell therapy: current limitations and potential strategies.
Blood Cancer J. 2021 Apr 6;11(4):69. doi: 10.1038/s41408-021-00459-7.
7
LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation.
Nat Chem Biol. 2021 Sep;17(9):937-946. doi: 10.1038/s41589-021-00770-1. Epub 2021 Mar 25.
10
GALA peptide improves the potency of nanobody-drug conjugates by lipid-induced helix formation.
Chem Commun (Camb). 2021 Feb 15;57(12):1434-1437. doi: 10.1039/d0cc07706b.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验